Synthace Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nanorobotics market is anticipated to grow at a substantial CAGR of 11.4% during the forecast period.

This Nanorobots market report work with respect to opportunities, challenges, drivers, market structures, and competitive landscape for the clients. The report is a complete overview of the market, covering various aspects including product definition, market segmentation based on various parameters, and the prevail...

Published: May 21, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.  AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she...

Synthace Ltd: Synthace Appoints Dr. Nick Jurascheck as VP of Engineering Jurascheck, a senior Engineering executive, brings over twenty years of experience to the role Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, today announced the appointment of Nick Jurascheck as VP of Engineering. Dr. Jurascheck brings with him more than twenty years of experience spanning senior technology roles in high-tech product companies and consultancies. Before joining Synthace, Nick worked at McLaren Applied in...